{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:02:06Z","timestamp":1784570526512,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The pharmacokinetics of the semisynthetic cannabinoid hexahydrocannabinol (HHC) and its 11-nor-carboxy- as well as 11-hydroxy-metabolites has already been the subject of research in various recent publications. However, further metabolism studies showed the presence of other, especially (side-chain-)hydroxylated metabolites in urine and serum. This study aimed to investigate the pharmacokinetics of these metabolites after oral (25\u00a0mg fruit gum) and inhalative (three puffs from vape) consumption, using serum and urine samples from a previous study. Serum (up to 48\u00a0h) and urine (up to five days) samples of six participants (three per consumption group) were collected at different time points and analyzed by LC-QqTOF and LC-QqLIT. Three metabolites (M1: side-chain-hydroxylated; M2: hydroxylated on alicyclic moiety; M3: 8-OH-HHC) were further investigated. The peak area ratios of analytes and internal standards were plotted against the time after consumption to obtain pharmacokinetic information. Overall, this study proved the presence of these metabolites in biological samples and provided pharmacokinetic insights for the first time. Differences between serum and urine, oral and inhalative consumption as well as inter-individual differences were observed. The investigated metabolites could partially serve as unambiguous consumption markers for HHC, as they are unlikely to be formed in vivo from corresponding \u0394\n                    <jats:sup>9<\/jats:sup>\n                    -tetrahydrocannabinol (THC) metabolites.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-62767-x","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:47:28Z","timestamp":1784566048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary pharmacokinetic investigations of hydroxylated metabolites after controlled inhalative and oral consumption of hexahydrocannabinol (HHC)"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8723-4405","authenticated-orcid":false,"given":"Lisa","family":"H\u00f6fert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5579-2217","authenticated-orcid":false,"given":"Willi","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7890-2162","authenticated-orcid":false,"given":"Isabelle","family":"M\u00f6sch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susen","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-5308","authenticated-orcid":false,"given":"Sven","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"62767_CR1","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1038\/s41598-023-38188-5","volume":"13","author":"F Russo","year":"2023","unstructured":"Russo, F. et al. Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC). Sci. Rep. 13, 11061 (2023).","journal-title":"Sci. Rep."},{"key":"62767_CR2","doi-asserted-by":"crossref","unstructured":"Collins, A. et al. Synthesis and characterization of the diastereomers of HHC and H4CBD. Nat Prod. Commun 18 (2023).","DOI":"10.1177\/1934578X231158910"},{"key":"62767_CR3","unstructured":"United Nations Convention on Psychotropic Substances. https:\/\/www.unodc.org\/pdf\/convention_1971_en.pdf. (1971). (accessed: 29.10.2025)."},{"key":"62767_CR4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0040-4020(01)99446-3","volume":"22","author":"Y Gaoni","year":"1966","unstructured":"Gaoni, Y., Mechoulam, R. & Hashish\u2014VII The isomerization of cannabidiol to tetrahydrocannabinols. Tetrahedron 22, 1481\u20131488 (1966).","journal-title":"Tetrahedron"},{"key":"62767_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/dta.3519","volume":"16","author":"I Ujv\u00e1ry","year":"2023","unstructured":"Ujv\u00e1ry, I. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review. Drug Test. Anal. 16, 127\u2013161 (2023).","journal-title":"Drug Test. Anal."},{"key":"62767_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42238-024-00226-y","volume":"6","author":"C Caprari","year":"2024","unstructured":"Caprari, C., Ferri, E., Vandelli, M. A., Citti, C. & Cannazza, G. An emerging trend in Novel Psychoactive Substances (NPSs): designer THC. J. Cannabis Res. 6, 21 (2024).","journal-title":"J. Cannabis Res."},{"key":"62767_CR7","unstructured":"United Nations Office on Drugs and Crime UNODC. SMART Forensics Update, Beyond Plants: Semi-Synthetics Diversify the Cannabis Market (2024). https:\/\/www.unodc.org\/unodc\/en\/scientists\/smart-forensics-update-vol-1.html (accessed: 29.10.2025)."},{"key":"62767_CR8","unstructured":"Ujv\u00e1ry, I. et al. Hexahydrocannabinol (HHC) and Related Substances. Technical Report. https:\/\/www.drugsandalcohol.ie\/38606 (2023)."},{"key":"62767_CR9","doi-asserted-by":"publisher","first-page":"10086","DOI":"10.1038\/s41598-025-93931-4","volume":"15","author":"L H\u00f6fert","year":"2025","unstructured":"H\u00f6fert, L. et al. Preliminary pharmacokinetic and psychophysical investigations after controlled oral and inhalative consumption of hexahydrocannabinol (HHC). Sci. Rep. 15, 10086 (2025).","journal-title":"Sci. Rep."},{"key":"62767_CR10","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s00204-024-03769-4","volume":"98","author":"LK Janssens","year":"2024","unstructured":"Janssens, L. K. et al. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with \u03b2-arrestin2 recruitment assays\u2014and how this matters for the harm potential of seized drugs. Arch. Toxicol. 98, 2619\u20132630 (2024).","journal-title":"Arch. Toxicol."},{"key":"62767_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/15563650.2024.2318409","volume":"62","author":"M Labadie","year":"2024","unstructured":"Labadie, M. et al. Hexahydrocannabinol poisoning reported to French poison centres. Clin. Toxicol. 62, 112\u2013119 (2024).","journal-title":"Clin. Toxicol."},{"key":"62767_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ipm.2024.3","volume":"41","author":"B O\u2019Mahony","year":"2024","unstructured":"O\u2019Mahony, B., O\u2019Malley, A., Kerrigan, O. & McDonald, C. HHC-induced psychosis: a case series of psychotic illness triggered by a widely available semisynthetic cannabinoid. Ir. J. Psychol. Med. 41, 1\u20134 (2024).","journal-title":"Ir. J. Psychol. Med."},{"key":"62767_CR13","doi-asserted-by":"publisher","unstructured":"Gameli, P. S. et al. Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-Hexahydrocannabinol. Clin. Chim. Acta. 120480 https:\/\/doi.org\/10.1016\/j.cca.2025.120480 (2025).","DOI":"10.1016\/j.cca.2025.120480"},{"key":"62767_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/jat\/bkad079","volume":"47","author":"SK Manier","year":"2023","unstructured":"Manier, S. K., Valdiviezo, J. A., Vollmer, A. C., Eckstein, N. & Meyer, M. R. Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC\u2013HRMS-MS. J. Anal. Toxicol. 47, 818\u2013825 (2023).","journal-title":"J. Anal. Toxicol."},{"key":"62767_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/jat\/bkae022","volume":"48","author":"F Pitterl","year":"2024","unstructured":"Pitterl, F., Pavlic, M., Liu, J. & Oberacher, H. Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography\u2013high-resolution tandem mass spectrometry. J. Anal. Toxicol. 48, 350\u2013358 (2024).","journal-title":"J. Anal. Toxicol."},{"key":"62767_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/dta.3740","volume":"17","author":"K Lindbom","year":"2025","unstructured":"Lindbom, K. et al. Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples. Drug Test. Anal. 17, 372\u2013386 (2025).","journal-title":"Drug Test. Anal."},{"key":"62767_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/00365513.2024.2333023","volume":"84","author":"P Pettersson-Pablo","year":"2024","unstructured":"Pettersson-Pablo, P. & Oxelbark, J. LC-MS\/MS analysis of 11-nor-9-carboxy-hexahydrocannabinol (HHC-COOH) and 11-hydroxy-hexahydrocannabinol (HHC-OH) for verification of hexahydrocannabinol (HHC) intake. Scand. J. Clin. Lab. Invest. 84, 109\u2013114 (2024).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"62767_CR18","doi-asserted-by":"publisher","first-page":"115918","DOI":"10.1016\/j.jpba.2023.115918","volume":"240","author":"G Kobidze","year":"2024","unstructured":"Kobidze, G. et al. The first LC-MS\/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine. J. Pharm. Biomed. Anal. 240, 115918 (2024).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"62767_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/jat\/bkae030","volume":"48","author":"R Kronstrand","year":"2024","unstructured":"Kronstrand, R., Roman, M., Green, H. & Truver, M. T. Quantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID-cases. J. Anal. Toxicol. 48, 235\u2013241 (2024).","journal-title":"J. Anal. Toxicol."},{"key":"62767_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/00365513.2024.2340039","volume":"84","author":"A Helander","year":"2024","unstructured":"Helander, A., Johansson, M., Vill\u00e9n, T. & Andersson, A. Appearance of hexahydrocannabinols as recreational drugs and implications for cannabis drug testing - focus on HHC, HHC-P, HHC-O and HHC-H. Scand. J. Clin. Lab. Invest. 84, 125\u2013132 (2024).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"62767_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/ph17020249","volume":"17","author":"A Di Trana","year":"2024","unstructured":"Di Trana, A. et al. Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study. Pharmaceuticals 17, 249 (2024).","journal-title":"Pharmaceuticals"},{"key":"62767_CR22","doi-asserted-by":"publisher","first-page":"112437","DOI":"10.1016\/j.forsciint.2025.112437","volume":"370","author":"L Lucuta","year":"2025","unstructured":"Lucuta, L. et al. Inhalation and oral administration of HHC products \u2013 Quantification of (9R)-, (9S)-Hexahydrocannabinol and metabolites in plasma and detectability in on-site drug tests for urine and oral fluid. Forensic Sci. Int. 370, 112437 (2025).","journal-title":"Forensic Sci. Int."},{"key":"62767_CR23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/14690667231200139","volume":"29","author":"W Schirmer","year":"2023","unstructured":"Schirmer, W., Auw\u00e4rter, V., Kaudewitz, J., Sch\u00fcrch, S. & Weinmann, W. Identification of human hexahydrocannabinol metabolites in urine. Eur. J. Mass. Spectrom. 29, 326\u2013337 (2023).","journal-title":"Eur. J. Mass. Spectrom."},{"key":"62767_CR24","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/metabo13121169","volume":"13","author":"C Falck J\u00f8rgensen","year":"2023","unstructured":"Falck J\u00f8rgensen, C., Rasmussen, S., Linnet, B., Thomsen, R. & K. & Evidence of 11-Hydroxy-hexahydrocannabinol and 11-Nor-9-carboxy-hexahydrocannabinol as Novel Human Metabolites of \u22069-Tetrahydrocannabinol. Metabolites 13, 1169 (2023).","journal-title":"Metabolites"},{"key":"62767_CR25","doi-asserted-by":"publisher","first-page":"116833","DOI":"10.1016\/j.jpba.2025.116833","volume":"261","author":"M Grapp","year":"2025","unstructured":"Grapp, M. et al. Detection of 11-nor-9-carboxy-hexahydrocannabinol (HHC-COOH) as metabolite of both hexahydrocannabinol (HHC) and \u22069-tetrahydrocannabinol (\u22069-THC) in routine forensic samples. J. Pharm. Biomed. Anal. 261, 116833 (2025).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"62767_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11419-007-0021-y","volume":"25","author":"K Watanabe","year":"2007","unstructured":"Watanabe, K. et al. Conversion of cannabidiol to \u22069-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in mice. Forensic Toxicol. 25, 16\u201321 (2007).","journal-title":"Forensic Toxicol."},{"key":"62767_CR27","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.3390\/molecules29143440","volume":"29","author":"A Di Trana","year":"2024","unstructured":"Di Trana, A. et al. QuEChERS Extraction and Simultaneous Quantification in GC-MS\/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid. Molecules 29, 3440 (2024).","journal-title":"Molecules"},{"key":"62767_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11419-023-00667-9","volume":"42","author":"R Tanaka","year":"2024","unstructured":"Tanaka, R. & Kikura-Hanajiri, R. Identification of hexahydrocannabinol (HHC), dihydro-iso-tetrahydrocannabinol (dihydro-iso-THC) and hexahydrocannabiphorol (HHCP) in electronic cigarette cartridge products. Forensic Toxicol. 42, 71\u201381 (2024).","journal-title":"Forensic Toxicol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62767-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:07:29Z","timestamp":1784567249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62767-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["62767"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-62767-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22712"}}